Patents Assigned to METRION BIOSCIENCES LIMITED
  • Publication number: 20210275499
    Abstract: The invention relates to heterocyclic sulfonamide derivatives and their use in the treatment and prophylaxis of autoimmune, inflammatory, cardiovascular, neuronal, auditory, renal and metabolic mediated diseases, and to compositions containing said derivatives and processes for their preparation.
    Type: Application
    Filed: July 5, 2019
    Publication date: September 9, 2021
    Applicant: METRION BIOSCIENCES LIMITED
    Inventors: Marc ROGERS, Robert KIRBY, Gakujun SHOMI, Takuya MATSUO, Satoru KOBAYASHI, Junichiro KANAZAWA, Nobutaka YAMAOKA, Makoto TORIZUKA, Koichi SUZAWA